APP and Alzheimer disease: The use of SSRIs may modify some disease process via increased neurogenesis, reduced oxidative stress and favourable Amyloid-β Precursor Protein (AβPP) processing [1], which has generated interest in their ability to treat Alzheimer’s disease (AD).